Panama’s Social Security Fund has exposed several organized corruption schemes operating within its walls. The institution’s director, Dino Mon, revealed details this week about networks involving fraudulent pensions, stolen medicines, and manipulated computer systems. These revelations come amid a sweeping administrative overhaul of the nation’s public health and pension provider.
Mon presented findings to the National Assembly’s Health Commission on March 11, outlining criminal operations that siphoned millions from public coffers. The schemes compromised patient care and undermined the financial stability of the crucial Social Security Fund (Caja de Seguro Social). Investigators with the nation’s Public Ministry (Ministerio Público) are now pursuing multiple criminal cases.
“We are confronting organized networks that operated with impunity for years,” Mon told legislators. [Translated from Spanish]
The director pledged full cooperation with prosecutors to hold perpetrators accountable. His administration has filed formal complaints and requested forensic audits to trace the illicit activities.
Fraudulent Pension Scheme Cost Millions
One elaborate fraud involved the illegal approval of 52 retirement pensions. The scheme caused an estimated $10 million in economic damage before its discovery. Officials filed a criminal complaint on January 12, detailing how the network manipulated digital records.
Perpetrators created entirely fictitious employment histories to generate pension rights. They even used personal data belonging to deceased individuals. The fraud relied on altering the institution’s core information systems to fabricate legitimate-looking records.
In response, the CSS has requested comprehensive digital forensic analysis from the Public Ministry. This audit aims to identify every public official and outside accomplice involved in the system manipulation. The pension scandal represents one of the most financially damaging corruption cases in the fund’s recent history.
Missing Fentanyl Reveals Drug Theft Network
A separate investigation uncovered systematic theft of controlled medicines, including a powerful synthetic opioid. The case gained national attention after 19,000 ampoules of Fentanyl vanished from CSS warehouses in 2022. That loss occurred before the current administration took office.
The initial probe began somewhat accidentally. A security guard found a medical case an anesthesiologist left in a hallway. Inside were 25 medicines, 12 of which were fentanyl ampoules. This discovery triggered a broader audit ordered by prosecutors in April 2023.
“This was not simple mismanagement. We are looking at an organized network that operated inside the institution,” Director Mon stated regarding the medicine thefts. [Translated from Spanish]
Auditors found multiple glaring irregularities. Controlled substances were dispensed without proper official prescriptions. Some prescriptions came from medical residents unauthorized to approve such drugs. The audit also revealed duplicate fentanyl requests for single patients and a complete lack of control over storage facility keys.
The National College of Pharmacists filed a complaint against former CSS director Enrique Lau Cortés and other officials for dereliction of duty. Lau Cortés never publicly released the audit results, which were forwarded to the Public Ministry for the criminal investigation. The case remains active.
Medicines Thrown in Trash for Later Retrieval
Another brazen operation emerged in Chiriquí province. CSS employees there allegedly threw bags of medicines into the trash. Homeless individuals, reportedly hired by the same staff, would then retrieve the bags from dumpsters. Mon disclosed this scheme during his legislative testimony.
This practice caused critical shortages of essential hypertension drugs like Irbesartan and Amlodipine. Patients needing these medications faced uncertain access because supplies were literally being thrown away. The seguro social system’s credibility suffered another blow with this discovery.
To combat the systemic vulnerability, the CSS implemented a new tracking system called SALMI. The United Nations donated this technology, which allows real-time monitoring of drug inventories. It significantly improves control over the supply chain from warehouse to patient.
Authorities also identified flaws in the institution’s old information system. That outdated software allowed multiple users to alter medicine shipment records without proper oversight. This weakness enabled massive losses and made accurate inventory control nearly impossible.
President Vows to End “Medicine Mafia”
The corruption fight reaches the highest levels of government. President José Raúl Mulino addressed the issue directly in his first national report on January 2, 2025. He promised to dismantle what he termed the “medicine mafia” inside the National Directorate of Pharmacy and Drugs.
That declaration drew a mixed response from professionals within the system. The Association of Pharmacists in State Service expressed regret over the president’s characterization. They argued it failed to reflect the dedication of most public health pharmacists.
Association president Edgar Andrión defended the directorate’s crucial role. He emphasized its work in supervising processes that ensure medication quality, efficacy, and safety nationwide. The actual director of the CSS continues to navigate these complex institutional challenges.
Employer Debt Forgiveness Scheme Uncovered
Another scheme manipulated the System of Income and Economic Benefits, known as SIPE. Detectives uncovered this fraud in September 2025. CSS employees allegedly hacked into employer accounts within the contribution database.
Their goal was simple and lucrative. They deleted employer debts totaling thousands of dollars. The conspirators also generated illegitimate credits favoring certain companies. This type of manipulation directly reduces the fund’s available resources for legitimate pensions and benefits.
Each corruption case follows a similar pattern of insider access and systemic weakness. Mon’s administration now faces the dual task of pursuing justice while implementing reforms. The director must rebuild public trust in an institution vital to millions of Panamanians. His success or failure will impact national health outcomes and pension security for years to come.